FDA
approval
· 2025-08-20
FDA Approved: MACITENTAN — Original Application (Sandoz Inc)
Summary
FDA approved a generic macitentan from Sandoz Inc through an original application for the treatment of pulmonary arterial hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for MACITENTAN (MACITENTAN)